Characterisation of plasma phosphorylated Tau181 in a middle‐aged birth cohort: Associations with cognitive decline, brain structural integrity, and accelerated ageing

The range of pTau181 levels observed suggests that blood biomarkers of AD may increase early in middle age, decades prior to any potential disease onset and possibly before any measurable cognitive decline or neurostructural abnormalities. Future assessment waves in the same cohort will elucidate whether plasma pTau181 in midlife is predictive of AD onset later in life.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70856_099207
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterisation of plasma phosphorylated Tau181 in a middle‐aged birth cohort: Associations with cognitive decline, brain structural integrity, and accelerated ageing

Sean Hogan, Tracy R. Melzer, Richie Poulton, Sandhya Ramrakha et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Characterisation of plasma phosphorylated Tau181 in a middle‐aged birth cohort: Associations with cognitive decline, brain structural integrity, and accelerated ageing

Sean Hogan, Tracy R. Melzer, Richie Poulton, Sandhya Ramrakha, Elizabeth Goodin, Renate Houts, Erin E. Cawston, Jesse Kokaua, David Ireland, Tim Anderson, Reremoana F. Theodore, Annchen R. Knodt, Antony Ambler, Wickliffe C. Abraham, Karen Sugden, P.D. Wilson, Kirsten Cheyne, Avshalom Caspi, Ben Williams, Ahmad R. Hariri, Terrie E. Moffitt, Brigid Ryan, Ashleigh Barrett‐Young
article en

Abstract

The range of pTau181 levels observed suggests that blood biomarkers of AD may increase early in middle age, decades prior to any potential disease onset and possibly before any measurable cognitive decline or neurostructural abnormalities. Future assessment waves in the same cohort will elucidate whether plasma pTau181 in midlife is predictive of AD onset later in life.

Alzheimer s & DementiaVol. 21(S2)
University of Auckland (NZ), Duke University (US), King's College London (GB), University of Canterbury (NZ), New Zealand Brain Research Institute (NZ), Brain Research New Zealand (NZ), University of Otago (NZ)
Openalex Percentile: Top 33%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.